Durgical
EN
Open the app

Hodgkin versus non-Hodgkin lymphoma

  • Look-alikes compared

Lymphoma usually starts as a painless lump in the neck, armpit or groin. Which kind it is decides how it spreads, how it is treated and how likely a cure is.

Updated

What it is

Lymphomas are cancers of lymphocytes that grow mainly in lymph nodes and other lymphoid tissue. Hodgkin lymphoma is defined by a small number of large malignant Reed–Sternberg cells surrounded by many reactive inflammatory cells. Non-Hodgkin lymphomas are a large family (most of B-cell origin) in which the malignant cells make up most of the tumour; they range from slow-growing (follicular) to very fast-growing (diffuse large B-cell, Burkitt).

The difference in one line

  • B symptoms: unexplained fever, drenching night sweats and weight loss of more than 10% in six months; they signal more advanced or aggressive disease.
  • Hodgkin lymphoma: peaks in young adults and again in older age; often a neck or mediastinal mass; can cause itching and, rarely, node pain after alcohol; linked to EBV in some cases.
  • Reed–Sternberg cells carry CD15 and CD30.
  • Diffuse large B-cell lymphoma is the commonest aggressive non-Hodgkin lymphoma; follicular lymphoma, with t(14;18) and BCL2, is the commonest slow-growing one.
  • Burkitt lymphoma (MYC, t(8;14)) is one of the fastest-growing human tumours: 'starry sky' pattern, jaw or abdominal mass, high risk of tumour lysis.
  • Risk factors for non-Hodgkin lymphoma include immune deficiency (HIV, transplant), autoimmune disease and infections such as H. pylori (gastric MALT lymphoma), EBV and HTLV-1.

Hodgkin and non-Hodgkin lymphoma

FeatureHodgkin lymphomaNon-Hodgkin lymphoma
Malignant cellFew Reed–Sternberg cells (CD15, CD30) among reactive cellsMalignant lymphocytes make up most of the node (mostly B cells)
AgeYoung adults and older adultsMostly older adults (Burkitt in children)
SpreadOrderly, to the next node groupScattered, often outside the nodes
Extranodal diseaseUncommon at diagnosisCommon (gut, skin, CNS, marrow)
OutlookMost patients curedVaries widely: indolent types relapse over years, aggressive types often curable

In clinical practice

  • A node larger than about 2 cm, hard, painless, growing for more than a few weeks, or above the collarbone (supraclavicular) needs a biopsy.
  • A young adult with a mediastinal mass and itching: think of Hodgkin lymphoma; also think of T-ALL, thymoma and germ cell tumours.
  • A large mediastinal mass can compress the airway or superior vena cava: sedation and lying flat can be dangerous.

How it is confirmed

  • An excision or core biopsy of a whole node is needed: fine-needle aspiration cannot show the architecture that classifies lymphoma.
  • Staging with PET-CT; full count, LDH, liver and kidney tests, and HIV and hepatitis B and C tests before treatment.
  • Persistent unexplained lymphadenopathy or a mediastinal mass: refer for biopsy; airway or vena cava compression is an emergency.

Common traps

  • Relying on fine-needle aspiration to diagnose lymphoma: the node architecture is needed.
  • Giving steroids before the biopsy: they can shrink the node and spoil the diagnosis.
  • Assuming Hodgkin and non-Hodgkin spread the same way: Hodgkin spreads to adjacent nodes, non-Hodgkin skips and goes extranodal.
  • Thinking tumour lysis in Burkitt lymphoma starts only with treatment: it can occur even before treatment.

Test yourself

Think of the answer, then tap the question to see it.

Why is a fine-needle aspirate not enough to diagnose lymphoma?

Lymphoma is classified by the architecture of the node (follicles, diffuse sheets, scattered Reed–Sternberg cells), which needs an excision or core biopsy.

Which markers identify Reed–Sternberg cells?

CD15 and CD30.

A patient with a large mediastinal mass needs a biopsy. Why can sedation be dangerous?

A big mass can compress the airway or the superior vena cava, and sedation or lying flat can make the compression critical.

Which slow-growing lymphoma carries t(14;18), and what does the translocation do?

Follicular lymphoma; t(14;18) switches on BCL2, which blocks apoptosis so the B cells live too long.

Add to my cards (4)

Elsewhere in DurgiPedia

Connections

← All of haematology

Educational content; it does not replace assessment by a doctor or your institution's protocols. It contains no doses.

Sources: Hodgkin lymphoma (MedlinePlus, US National Library of Medicine, 2025); Non-Hodgkin lymphoma (MedlinePlus, US National Library of Medicine, 2025); Lymphadenopathy (StatPearls (NCBI Bookshelf), 2026); Hodgkin Lymphoma Treatment (PDQ®)–Patient Version (National Cancer Institute (NCI), 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.